Ridout & Maybee LLP is a full-service Canadian IP firm with offices in Toronto, Ottawa and Burlington serving clients across the country and internationally. Our firm consistently ranks as one of Canada’s top IP law firms in both Canadian and international surveys of in-house counsel.
We understand the business of innovation, and the vital role that IP plays in today’s competitive, market-driven economy.
Meet Our People
The lawyers and patent and trademark agents at Ridout & Maybee LLP bring both legal expertise and real-world industry knowledge to work for our clients. Many of our professionals were leaders in their technical field prior to working in intellectual property law, and hold advanced degrees and certifications.
News
Joanna Pitkin joins the Ridout & Maybee LLP partnership
Ridout & Maybee LLP is pleased to announce that Joanna Pitkin has joined the partnership, effective January 1, 2020.
Partner Benjamin Mak Awarded 2019 Lexpert Rising Stars: Leading Lawyers under 40 Award
The firm is pleased to announce that partner Benjamin Mak is a recipient of a 2019 Lexpert Rising Stars: Leading Lawyers Under 40 award!
Changes to Canadian Patent Law – Updated Fees
In light of the recent changes to Canadian patent law and practice, effective October 30, 2019, we have made a number of important amendments to our schedule of fees for patents.
Global Trademark Protection and Enforcement
The globalization of business may make the world seem smaller but it makes your brand potential much greater.
The Role of AI in Medical Imaging
The current role that Artificial Intelligence (“AI”) plays in society can be summarised by a single quote – “AI is the new electricity.”
Overview of Licences Available in the Cannabis Supply Chain
Prior to the instatement of the Cannabis Act on October 17, 2018, access to cannabis was limited to uses for medical purposes.
Industry
Joanna Pitkin joins the Ridout & Maybee LLP partnership
Ridout & Maybee LLP is pleased to announce that Joanna Pitkin has joined the partnership, effective January 1, 2020.
Partner Benjamin Mak Awarded 2019 Lexpert Rising Stars: Leading Lawyers under 40 Award
The firm is pleased to announce that partner Benjamin Mak is a recipient of a 2019 Lexpert Rising Stars: Leading Lawyers Under 40 award!
Changes to Canadian Patent Law – Updated Fees
In light of the recent changes to Canadian patent law and practice, effective October 30, 2019, we have made a number of important amendments to our schedule of fees for patents.
Global Trademark Protection and Enforcement
The globalization of business may make the world seem smaller but it makes your brand potential much greater.
The Role of AI in Medical Imaging
The current role that Artificial Intelligence (“AI”) plays in society can be summarised by a single quote – “AI is the new electricity.”
Overview of Licences Available in the Cannabis Supply Chain
Prior to the instatement of the Cannabis Act on October 17, 2018, access to cannabis was limited to uses for medical purposes.
Blog
Joanna Pitkin joins the Ridout & Maybee LLP partnership
Ridout & Maybee LLP is pleased to announce that Joanna Pitkin has joined the partnership, effective January 1, 2020.
Partner Benjamin Mak Awarded 2019 Lexpert Rising Stars: Leading Lawyers under 40 Award
The firm is pleased to announce that partner Benjamin Mak is a recipient of a 2019 Lexpert Rising Stars: Leading Lawyers Under 40 award!
Changes to Canadian Patent Law – Updated Fees
In light of the recent changes to Canadian patent law and practice, effective October 30, 2019, we have made a number of important amendments to our schedule of fees for patents.
Global Trademark Protection and Enforcement
The globalization of business may make the world seem smaller but it makes your brand potential much greater.
The Role of AI in Medical Imaging
The current role that Artificial Intelligence (“AI”) plays in society can be summarised by a single quote – “AI is the new electricity.”
Overview of Licences Available in the Cannabis Supply Chain
Prior to the instatement of the Cannabis Act on October 17, 2018, access to cannabis was limited to uses for medical purposes.